Drug research is changing and there are opportunities for growth, says Christopher Fikry, the new CEO of clinical trial tech firm Clario. Fikry, who Clario named as its new chief last month, shared ...

Clinical trial tech company Clario has sealed its second acquisition in a week, doubling down further on neuroscience by picking up imaging specialist NeuroRx. NeuroRx founder and CEO Douglas Arnold, ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

PHILADELPHIA, March 17, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have acquired NeuroRx, a leader in imaging ...

Thermo Fisher Scientific (NYSE:TMO) has confirmed a deal to acquire clinical trial data management firm Clario Holdings from a shareholder group led by Astorg and Nordic Capital, Novo Holding, and ...

Clario strengthens its leadership in digital endpoint data collection with the acquisition of WCG's eCOA business, enhancing support for neuroscience clinical trials. Acquisition expands Clario's ...

(Reuters) - Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound ...

Thermo Fisher (NYSE:TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data management firm at around $10B, the Financial Times reported, citing people ...

Clario's third annual ESG report for the calendar year 2023 highlights advancements in responsible artificial intelligence (AI), employee program investments, and ambitious science-based ...

Allison Worldwide, Ogilvy, Fleishman-Hillard, JWT, Grey and In-house Alums Launch with 30+ Senior Client Counselors, Executive Advisors, and Global Partner Agencies NEW YORK, Oct. 15, 2025 /PRNewswire ...